SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-09-009038
Filing Date
2009-02-17
Accepted
2009-02-17 16:16:43
Documents
2
Group Members
D. E. SHAW & CO., L.P.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 v138028_sc13ga.htm SC 13G/A 180847
2 v138028_ex1.htm EX-1 9549
  Complete submission text file 0001144204-09-009038.txt   192373
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Subject) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-60323 | Film No.: 09614015
SIC: 2834 Pharmaceutical Preparations

Mailing Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036
Business Address 120 WEST FORTY-FIFTH STREET 39TH FLOOR NEW YORK NY 10036 (212) 478-0000
D. E. Shaw Valence Portfolios, L.L.C. (Filed by) CIK: 0001294704 (see all company filings)

IRS No.: 134046559 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A